THE API POWDER DIARIES

“The present circumstance has uncovered some structural weaknesses in the EU’s medicines offer chain plus a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that provide chain challenges be resolved in an EU pharmaceutical technique envisioned to be launched by the tip of the calend